Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Saroglitazar (magnesium)

Saroglitazar magnesium is a novel peroxisome proliferator-activated receptor (PPAR) agonist with predominant PPARα and moderate PPARγ activity with EC50 values of 0.65 pM and 3 nM in HepG2 cells, respectively.

Product Specifications

CAS Number

[1639792-20-3]

UNSPSC

12352005

Target

PPAR

Type

Reference compound

Related Pathways

Cell Cycle/DNA Damage; Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor

Applications

Metabolism-sugar/lipid metabolism

Field of Research

Metabolic Disease

Assay Protocol

https://www.medchemexpress.com/Saroglitazar-Magnesium.html

Purity

98.85

Solubility

DMSO : 125 mg/mL (ultrasonic)

Smiles

CCO([Mg+2]1(O(CC)[C@H](C([O-]1)=O)CC2=CC=C(OCCN3C(C)=CC=C3C4=CC=C(SC)C=C4)C=C2)[O-]C5=O)[C@H]5CC6=CC=C(OCCN7C(C)=CC=C7C8=CC=C(SC)C=C8)C=C6

Molecular Formula

C50H56MgN2O8S2

Molecular Weight

901.42

References & Citations

[1]Jain MR, et al. Saroglitazar, a novel PPARα/γ agonist with predominant PPARα activity, shows lipid-lowering effects in preclinical models. Pharmacol Res Perspect. 2015 Jun;3 (3) :e00136.

Shipping Conditions

Room Temperature

Storage Conditions

4°C (Powder, sealed storage, away from moisture)

Scientific Category

Reference compound1

Clinical Information

Phase 4

Isoform

PPARα; PPARγ

Citation 01

BMC Complement Med Ther. 2021 Apr 10;21 (1) :118.|Patent. US20210275504A1.|Acta Pharm Sin B. 2025 Sep 19.|Ann Med. 2025 Dec;57 (1) :2497112.|Cell Biol Toxicol. 2021 Apr;37 (2) :293-311.|iScience. 2025 Apr 3;28 (5) :112344.|Medicina (Kaunas) . 2025 Jun 26;61 (7) :1157.|Patent. US20190388398A1.|Sci Adv. 2025 Sep 26;11 (39) :eads3731.|SSRN. 2024 May 30.

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Mouse Lipe Pre-designed siRNA Set B
SI107585B 1 Each

Mouse Lipe Pre-designed siRNA Set B

Ask
View Details
Vanillin For Synthesis
121080 500 500 g

Vanillin For Synthesis

Ask
View Details
N- (2-Chlorotrityl resin) -glycine N-hydroxysuccinimide ester
sc-470600 1 g

N- (2-Chlorotrityl resin) -glycine N-hydroxysuccinimide ester

Ask
View Details
RSK1, phosphorylated (Ser363) (Ribosomal S6 Kinase 1, RSK-1, 90kD Ribosomal Protein S6 Kinase 1, p90-RSK 1, p90RSK1, p90S6K, MAP Kinase-activated Protein Kinase 1a, MAPK-activated Protein Kinase 1a, MAPKAP Kinase 1a, MAPKAPK1A, MAPKAPK-1a, Ribosomal Protein S6 Kinase alpha-1, RPS6KA1, S6K-alpha-1) (MaxLight 550) discontinued
R9399-02N-ML550 100 µL

RSK1, phosphorylated (Ser363) (Ribosomal S6 Kinase 1, RSK-1, 90kD Ribosomal Protein S6 Kinase 1, p90-RSK 1, p90RSK1, p90S6K, MAP Kinase-activated Protein Kinase 1a, MAPK-activated Protein Kinase 1a, MAPKAP Kinase 1a, MAPKAPK1A, MAPKAPK-1a, Ribosomal Protein S6 Kinase alpha-1, RPS6KA1, S6K-alpha-1) (MaxLight 550) discontinued

Ask
View Details
Anti-CD10/MME Polyclonal Antibody
PHC33001 100 μg

Anti-CD10/MME Polyclonal Antibody

Ask
View Details
Recombinant Bacillus cereus N- (5'-phosphoribosyl)anthranilate isomerase
MBS1194722-01 0.02 mg (E-Coli)

Recombinant Bacillus cereus N- (5'-phosphoribosyl)anthranilate isomerase

Ask
View Details